JP2007269667A - Antibacterial agent - Google Patents

Antibacterial agent Download PDF

Info

Publication number
JP2007269667A
JP2007269667A JP2006096017A JP2006096017A JP2007269667A JP 2007269667 A JP2007269667 A JP 2007269667A JP 2006096017 A JP2006096017 A JP 2006096017A JP 2006096017 A JP2006096017 A JP 2006096017A JP 2007269667 A JP2007269667 A JP 2007269667A
Authority
JP
Japan
Prior art keywords
sasanqua
extract
antibacterial
antibacterial agent
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006096017A
Other languages
Japanese (ja)
Other versions
JP4791873B2 (en
Inventor
Satoshi Nishimura
聡 西村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naris Cosmetics Co Ltd
Original Assignee
Naris Cosmetics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naris Cosmetics Co Ltd filed Critical Naris Cosmetics Co Ltd
Priority to JP2006096017A priority Critical patent/JP4791873B2/en
Publication of JP2007269667A publication Critical patent/JP2007269667A/en
Application granted granted Critical
Publication of JP4791873B2 publication Critical patent/JP4791873B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide an antibacterial agent by using a natural material without having problems in safety such as skin irritation, etc., and a cosmetic and skin preparation for external use blended with the antibacterial agent. <P>SOLUTION: The cosmetic and skin preparation for external use having a sufficient antibacterial activity and excellent in safety are provided by containing an extract obtained from Camellia sasanqua especially the extract obtained from the leaves of the Camellia sasanqua, by ≥0.1%, without using a preservative having skin irritation such as para-oxybenzoic acid ester, etc. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、天然素材であり優れた抗菌性を有するザザンカの葉の抽出物を配合する抗菌剤に関する。 The present invention relates to an antibacterial agent containing a Zazanka leaf extract which is a natural material and has excellent antibacterial properties.

化粧料には、外部から混入してくる微生物の増殖を抑制し、経時とともに死滅させ製品の劣化を防止する目的で抗菌剤が使用される。代表的なものとして、パラオキシ安息香酸エステルが汎用されている。パラオキシ安息香酸エステルは、食品にも汎用されているが、過去アレルギーが認められた経緯があり、皮膚刺激性に問題が指摘されており、化粧料への配合に関しては配合の上限が規定されている。その他、安息香酸塩、サリチル酸塩やデヒドロ酢酸塩もよく使用されるがパラオキシ安息香酸エステルと同様に皮膚刺激の問題が指摘されている。 In cosmetics, antibacterial agents are used for the purpose of suppressing the growth of microorganisms mixed in from the outside and killing them with time to prevent the deterioration of the product. As a representative one, paraoxybenzoic acid esters are widely used. Although paraoxybenzoic acid esters are widely used in foods, there is a history of allergies in the past, and problems with skin irritation have been pointed out. Yes. In addition, benzoate, salicylate, and dehydroacetate are often used, but skin irritation problems have been pointed out as in the case of paraoxybenzoate.

近年、フェノキシエタノールによって抗菌性をもたせる動きがあるが、皮膚刺激の問題は回避できているとは言えない。また、天然系の抗菌性を有する物質としては、ヒノキチオール、モノカプリル酸グリセリド、カチオン系アミノ酸誘導体、ビサボロール、グリコール類、及び植物抽出液としてのローズマリー抽出液やグレープフルーツ種子抽出液等が知られており、それらを併用して微生物の増殖を抑えることも試されている。しかしながら、ヒノキチオールは、鉄イオンの存在下で褐変を起こすことが知られている。モノカプリル酸グリセリルは、水存在下でエステル結合が加水分解作用により遊離したカプリル酸が発生し、その臭いが好ましくない。
特開2002−226386号公報 特開2003−113013号公報
In recent years, there has been a movement to provide antibacterial properties with phenoxyethanol, but the problem of skin irritation cannot be avoided. As natural antibacterial substances, hinokitiol, monocaprylic acid glycerides, cationic amino acid derivatives, bisabolol, glycols, rosemary extract as a plant extract, grapefruit seed extract, etc. are known. It has also been tried to suppress the growth of microorganisms by using them together. However, hinokitiol is known to brown in the presence of iron ions. In glyceryl monocaprylate, caprylic acid in which an ester bond is liberated by hydrolysis action in the presence of water is generated, and its odor is not preferable.
JP 2002-226386 A JP 2003-1113013 A

本発明の課題は、皮膚刺激等の安全面での問題のない新たな抗菌剤の提供である。 An object of the present invention is to provide a new antibacterial agent having no safety problems such as skin irritation.

本発明者は、係る情況に鑑み鋭意研究を重ねた結果、サザンカの葉の抽出物が抗菌活性を有することを見出し、本発明の完成に至った。即ち、本発明は、サザンカの葉の抽出物を特徴とする抗菌剤である。 As a result of intensive studies in view of the circumstances, the present inventor has found that the extract of the leaves of sasanqua has antibacterial activity, and has completed the present invention. That is, the present invention is an antibacterial agent characterized by an extract of sasanqua leaves.

本発明によれば、サザンカ葉抽出物を含むことを特徴とする抗菌剤を配合することにより、パラオキシ安息香酸エステル等の皮膚刺激を有する防腐剤を使用せずして十分な抗菌作用を有する安全性に優れた化粧料の提供が可能となる。 According to the present invention, by adding an antibacterial agent characterized by containing a sasanqua leaf extract, a safety having a sufficient antibacterial action without using a preservative having skin irritation such as paraoxybenzoate ester It is possible to provide cosmetics with excellent properties.

発明実施の最良の形態BEST MODE FOR CARRYING OUT THE INVENTION

本発明のサザンカの葉の抽出物は、単独でも十分な抗菌性を示すが、少量のエタノール、フェノキシエタノール、ヒノキチオール、モノカプリル酸グリセリド、カチオン系アミノ酸誘導体、ビサボロールや1,2−ペンタンジオール、1,2−ヘキサンジオール等の抗菌剤を併用することによって、相乗的に抗菌作用や抗菌範囲が向上する。 The extract of the sasanqua leaves of the present invention exhibits sufficient antibacterial properties by itself, but a small amount of ethanol, phenoxyethanol, hinokitiol, monocaprylic acid glycerides, cationic amino acid derivatives, bisabolol and 1,2-pentanediol, 1, By using an antibacterial agent such as 2-hexanediol in combination, the antibacterial action and the antibacterial range are synergistically improved.

本発明の抗菌剤には、上記した必須成分の他に通常の化粧品や医薬品、医薬部外品等に用いられる他の成分、例えば、ビタミンB2類、ビタミンB6類、ビタミンC類、ビタミンD類、ニコチン酸類、ビタミンE類、ビタミンP、ビオチン等のビタミン類、アミノ酸及びアミノ酸誘導体、ホホバ油、スクワラン等の油分、グリセリン、ソルビトール、1,3−ブチレングリコール等のグリコール類、コラーゲン、ヒアルロン酸等の高分子保湿剤、酸化防止剤、界面活性剤、グリチルリチン酸誘導体等の消炎剤、各種植物抽出物、カルボキシビニルポリマー等の増粘剤、香料、水、アルコール、色剤、ポリエチレン等の樹脂粉末等を必要に応じて適宜配合することができる。 In addition to the above-mentioned essential components, the antibacterial agent of the present invention includes other components used in normal cosmetics, pharmaceuticals, quasi drugs, etc., for example, vitamin B2, vitamin B6, vitamin C, vitamin D Vitamins such as nicotinic acids, vitamin E, vitamin P, biotin, amino acids and amino acid derivatives, oils such as jojoba oil and squalane, glycols such as glycerin, sorbitol, and 1,3-butylene glycol, collagen, hyaluronic acid, etc. Polymer moisturizers, antioxidants, surfactants, flame retardants such as glycyrrhizic acid derivatives, various plant extracts, thickeners such as carboxyvinyl polymer, flavoring, water, alcohol, colorants, resin powders such as polyethylene Etc. can be appropriately blended as necessary.

本発明に用いることができるサザンカの葉の抽出物の各種化粧料に対する配合量は、化粧料の実施態様、化粧料の使用形態などに応じて変動させることが可能で特に限定されない。原則的には、化粧料中に有効量存在すれば良いが、一般的な配合量は、化粧料組成物中0.001〜5質量%であり、好ましくは0.01〜3.0質量%、更に好ましくは0.1〜1.0質量%であるが、化粧料の剤型や処方内容により適正量は特に限定することはできないための目安である。 The blending amount of the extract of the leaf of sasanqua that can be used in the present invention with respect to various cosmetics can be varied according to the embodiment of the cosmetics, the usage form of the cosmetics, etc., and is not particularly limited. In principle, an effective amount may be present in the cosmetic, but the general blending amount is 0.001 to 5% by mass, preferably 0.01 to 3.0% by mass in the cosmetic composition. More preferably, it is 0.1 to 1.0% by mass, but this is an indication that the appropriate amount cannot be particularly limited depending on the dosage form of the cosmetic and the content of the formulation.

本発明に係る化粧料への適用範囲は、剤型等による制限はなく、全ての化粧料に適用が可能である。 The range of application to the cosmetic according to the present invention is not limited by the dosage form, and can be applied to all cosmetics.

例えば、本発明にかかる有効成分をクリーム、乳液、化粧水、パック剤、洗顔料などの各種基礎化粧料、ファンデーション、口紅、ほほ紅、白粉などの各種メーキャップ料、洗髪料、養毛剤、シャンプー、リンスなどの各種頭髪用化粧料、石鹸、美爪料、オーデコロン等その他化粧料に対して適用可能である。また、前記各種化粧料の実施態様は、溶液、エマルジョン、軟膏、ゾル、ゲル、パウダー、スプレー等の各種態様においても適用可能である。 For example, the active ingredients according to the present invention include various basic cosmetics such as creams, milky lotions, lotions, packs, facial cleansers, foundations, lipsticks, cheeks, white powders, makeup products, hair shampoos, hair nourishing agents, shampoos, rinses. It is applicable to other cosmetics such as various hair cosmetics such as soap, beauty nail, and cologne. The embodiments of the various cosmetics can also be applied to various embodiments such as solutions, emulsions, ointments, sols, gels, powders, and sprays.

以下、本発明を実施例により更に具体的に説明するが、本発明は実施例に限定されることはない。 EXAMPLES Hereinafter, although an Example demonstrates this invention further more concretely, this invention is not limited to an Example.

〔サザンカの葉の抽出物の製造〕
まず、本発明にかかる皮膚外用剤において特徴的なサザンカの葉の抽出物の製造例について説明する。
[Manufacture of sasanqua leaf extract]
First, the manufacture example of the extract of the leaf of a sasanqua characteristic in the skin external preparation concerning this invention is demonstrated.

〔実施例1から得られるエキスの作成〕
原材料として、サザンカの葉を20g使用した。前記原材料20gにエタノール100mLを加え、90℃で6時間加熱抽出した後上澄みを遠心分離し、比較的大きい浮遊物を除去したあと、メッシュ径0.22μmのろ紙を用いてろ過する。ロータリーエバポレーターにて減圧濃縮し、サザンカ葉エキス約0.5gを得た。
[Preparation of extract obtained from Example 1]
As raw material, 20 g of sasanqua leaves were used. 100 mL of ethanol is added to 20 g of the raw material, and the mixture is heated and extracted at 90 ° C. for 6 hours. The supernatant is centrifuged to remove relatively large suspended matters, and then filtered using a filter paper having a mesh diameter of 0.22 μm. Concentration under reduced pressure using a rotary evaporator gave about 0.5 g of sasanqua leaf extract.

〔細菌に対する抗菌作用〕
E.coliを用いて、ペーパーディスク法(直径6mmのペーパーディスク使用)にて植物抽出物の抗菌作用を調べた。試料は、上記抽出物を1w/v%となるようにジメチルスルホキシド(DMSO)に溶解して用いた。培養は、Soybean-Casein Digest
Broth(SCDLP)培地を用いて、嫌気下37℃3日間行った。その結果を表1に示す。表1から分かるように、サザンカ抽出物から得られた抽出物には1%の濃度で抗菌・殺菌作用が確認された。なお、抗菌作用の評価は以下の基準で行った。
++;阻止円の直径20mm以上
+ ;阻止円の直径12mm以上
± ;阻止円の直径 8mm以下
[Antimicrobial activity against bacteria]
E. The antibacterial action of the plant extract was examined by the paper disk method (using a paper disk having a diameter of 6 mm) using E. coli. The sample was used by dissolving the above extract in dimethyl sulfoxide (DMSO) so as to be 1 w / v%. Culture is Soybean-Casein Digest
Broth (SCDLP) medium was used under anaerobic conditions at 37 ° C. for 3 days. The results are shown in Table 1. As can be seen from Table 1, the antibacterial and bactericidal action was confirmed in the extract obtained from the sasanqua extract at a concentration of 1%. The antibacterial action was evaluated according to the following criteria.
++: Blocking circle diameter 20 mm or more +; Blocking circle diameter 12 mm or more ±; Blocking circle diameter 8 mm or less

Figure 2007269667
Figure 2007269667

〔真菌に対する抗菌作用〕
A.nigerを用いて、ペーパーディスク法(直径6mmのペーパーディスク使用)にて植物抽出物の抗菌作用を調べた。試料は、上記抽出物を1w/v%となるようにジメチルスルホキシド(DMSO)に溶解して用いた。培養は、Glucose Peptone Agar
with Lecithin & Polysorbate 80(GDLP)培地を用いて、嫌気下37℃3日間行った。その結果を表2に示す。表2から分かるように、サザンカ抽出物から得られた抽出物には1%の濃度で抗菌・殺菌作用が確認された。なお、抗菌作用の評価は以下の基準で行った。
++;阻止円の直径20mm以上
+ ;阻止円の直径12mm以上
± ;阻止円の直径 8mm以下
[Antimicrobial activity against fungi]
A. Using niger, the antibacterial action of the plant extract was examined by the paper disc method (using a paper disc having a diameter of 6 mm). The sample was used by dissolving the above extract in dimethyl sulfoxide (DMSO) so as to be 1 w / v%. Culture is Glucose Peptone Agar
With Lecithin & Polysorbate 80 (GDLP) medium, it was performed under anaerobic conditions at 37 ° C. for 3 days. The results are shown in Table 2. As can be seen from Table 2, antibacterial and bactericidal action was confirmed in the extract obtained from the sasanqua extract at a concentration of 1%. The antibacterial action was evaluated according to the following criteria.
++: Blocking circle diameter 20 mm or more +; Blocking circle diameter 12 mm or more ±; Blocking circle diameter 8 mm or less

Figure 2007269667
Figure 2007269667

〔実験例2:抗菌力(チャレンジテスト)の確認〕
サザンカの葉の抽出物において、法定5菌種(S.aureus、E.coli.、Ps.aerginosa、C.arbicans、A.niger)に対する抗菌性の確認試験を行った。試料は、サザンカ葉エキスを含有する化粧水、サザンカ葉エキスの溶剤としてエタノールを含有する化粧水を調製し試験に供した。
[Experiment 2: Confirmation of antibacterial activity (challenge test)]
The extract of sasanqua leaves was subjected to antibacterial confirmation tests against five legal species (S. aureus, E. coli, Ps. Aerginosa, C. arbicans, A. niger). As samples, a lotion containing a sasanqua leaf extract and a lotion containing ethanol as a solvent for the sasanqua leaf extract were prepared and subjected to the test.

〔判定基準〕
判定基準については、以下の5段階にて評価した。
◎:顕著な菌数の減少が見られた。
○:菌数の減少が見られた。
△:穏やかな菌数の減少が見られた。
▲:菌数の減少及び増加がみられなかった
×:菌数の増加が見られた。
[Criteria]
Evaluation criteria were evaluated in the following five stages.
(Double-circle): The remarkable reduction | decrease in the number of bacteria was seen.
○: A decrease in the number of bacteria was observed.
Δ: A moderate decrease in the number of bacteria was observed.
▲: Decrease or increase in the number of bacteria was not observed ×: Increase in the number of bacteria was observed.

サザンカ葉抽出物の溶剤としてエタノールを含む抗菌作用について、「真菌」に対する効果を表3に示す。 Table 3 shows the effect on “fungi” for the antibacterial action including ethanol as a solvent for the sasanqua leaf extract.

Figure 2007269667
Figure 2007269667

「細菌」に対する効果を表4に示す。 Table 4 shows the effect on “bacteria”.

Figure 2007269667
Figure 2007269667

表3、4の結果から、パラオキシ安息香酸エステルを使用せずとも、化粧料の品質を維持する為に十分な抗菌作用を示すことを確認した。 From the results of Tables 3 and 4, it was confirmed that sufficient antibacterial action was exhibited to maintain the quality of cosmetics without using paraoxybenzoate.

次に本発明に係るサザンカ葉抽出物とエタノールを併用した具体的な化粧料について説明する。 Next, the specific cosmetics using the sasanqua leaf extract and ethanol according to the present invention will be described.

以下に本発明の処方例を挙げる。
<処方例1>化粧水
(質量%)
サザンカの葉の抽出物 5.0
エタノール 5.0
グリセリン 5.0
ポリオキシエチレンソルビタンモノラウレート(20E.0) 1.5
酸化防止剤 適 量
精製水 残 部
The formulation example of this invention is given to the following.
<Prescription Example 1> Lotion (mass%)
Sasanqua leaf extract 5.0
Ethanol 5.0
Glycerin 5.0
Polyoxyethylene sorbitan monolaurate (20E.0) 1.5
Antioxidant Appropriate amount of purified water balance

<処方例2>化粧用クリーム
(質量%)
サザンカの葉の抽出物 0.001
エタノール 5.0
ミツロウ 2.0
ステアリルアルコール 5.0
ステアリン酸 8.0
スクワラン 10.0
自己乳化型グリセリルモノステアレート 3.0
ポリオキシエチレンセチルエーテル(20E.0) 1.0
1,3−ブチレングリコール 5.0
水酸化カリウム 0.3
香料 適量
酸化防止剤 適量
精製水 残部
<Formulation example 2> Cosmetic cream (mass%)
Sasanqua leaf extract 0.001
Ethanol 5.0
Beeswax 2.0
Stearyl alcohol 5.0
Stearic acid 8.0
Squalane 10.0
Self-emulsifying glyceryl monostearate 3.0
Polyoxyethylene cetyl ether (20E.0) 1.0
1,3-butylene glycol 5.0
Potassium hydroxide 0.3
Perfume Appropriate amount Antioxidant Appropriate amount Purified water The rest

<処方例3>乳液
(質量%)
サザンカの葉の抽出物 1.0
エタノール 5.0
スクワラン 8.0
ワセリン 2.0
ミツロウ 0.5
ソルビタンセスキオレエート 0.8
ポリオキシエチレンオレイルエーテル(20E.0) 1.2
カルボキシビニルポリマー 0.2
水酸化カリウム 0.1
1.3−ブチレングリコール 7.0
香料 適量
酸化防止剤 適量
精製水 残部
<Prescription Example 3> Emulsion (mass%)
Sasanqua leaf extract 1.0
Ethanol 5.0
Squalane 8.0
Vaseline 2.0
Beeslow 0.5
Sorbitan sesquioleate 0.8
Polyoxyethylene oleyl ether (20E.0) 1.2
Carboxyvinyl polymer 0.2
Potassium hydroxide 0.1
1.3-Butylene glycol 7.0
Perfume Appropriate amount Antioxidant Appropriate amount Purified water The rest

<処方例4>パック剤
(質量%)
サザンカの葉の抽出物 0.1
エタノール 5.0
酢酸ビニル樹脂エマルジョン 15.0
ポリビニルアルコール 10.0
ホホバ油 3.0
グリセリン 5.0
酸化チタン 8.0
カオリン 7.0
香料 適量
酸化防止剤 適量
精製水 残部
<Prescription Example 4> Packing agent (mass%)
Sasanqua leaf extract 0.1
Ethanol 5.0
Vinyl acetate resin emulsion 15.0
Polyvinyl alcohol 10.0
Jojoba oil 3.0
Glycerin 5.0
Titanium oxide 8.0
Kaolin 7.0
Perfume Appropriate amount Antioxidant Appropriate amount Purified water The rest

<処方例5>軟膏
(質量%)
サザンカの葉の抽出物 3.0
エタノール 5.0
酢酸トコフェロール 0.5
パラジメチルアミノ安息香酸オクチル 4.0
ブチルメトキシベンゾイルメタン 4.0
ステアリルアルコール 18.0
モクロウ 20.0
グリセリンモノステアリン酸エステル 0.3
ワセリン 33.0
香料 適量
酸化防止剤 適量
精製水 残部
<Prescription Example 5> Ointment (mass%)
Sasanqua leaf extract 3.0
Ethanol 5.0
Tocopherol acetate 0.5
Octyl paradimethylaminobenzoate 4.0
Butylmethoxybenzoylmethane 4.0
Stearyl alcohol 18.0
Owl 20.0
Glycerin monostearate 0.3
Vaseline 33.0
Perfume Appropriate amount Antioxidant Appropriate amount Purified water The rest

<処方例6>アイシャドウ
(質量%)
サザンカの葉の抽出物 0.01
エタノール 5.0
酸化防止剤 適量
流動パラフィン 6.0
メチルポリシロキサン 2.0
香料 適量
セスキオレイン酸ソルビタン 2.0
タルク 45.0
マイカ 15.0
セリサイト 5.0
顔料 14.5
パール顔料 10.0
<Prescription Example 6> Eyeshadow (mass%)
Sasanqua leaf extract 0.01
Ethanol 5.0
Antioxidant appropriate amount liquid paraffin 6.0
Methylpolysiloxane 2.0
Perfume appropriate amount sorbitan sesquioleate 2.0
Talc 45.0
Mica 15.0
Sericite 5.0
Pigment 14.5
Pearl pigment 10.0

上記した処方例1〜6にて作成した化粧料を各化粧料について健常女性パネラー20名(計120名)に2週間使用してもらい使用感触及び皮膚刺激について確認した。その結果、1名の皮膚刺激も見られず使用感触も十分に満足する回答を得た。 The cosmetics prepared in the above-mentioned prescription examples 1 to 6 were used by 20 healthy female panelists (120 persons in total) for each cosmetic for 2 weeks, and the use feeling and skin irritation were confirmed. As a result, no skin irritation was seen by one person, and an answer that fully satisfied the feeling of use was obtained.

本発明によれば、サザンカの葉の抽出物を含むことを特徴とする抗菌剤を配合する化粧料が提供され、該化粧料は、パラオキシ安息香酸エステルを使用せずして、十分な抗菌作用を有することによって安全性に優れたものである。 According to the present invention, there is provided a cosmetic comprising an antibacterial agent characterized by containing an extract of sasanqua leaves, and the cosmetic has sufficient antibacterial activity without using a paraoxybenzoic acid ester. By having, it is excellent in safety.

Claims (3)

サザンカから得られた抽出物を含有することを特徴とする抗菌剤。 An antibacterial agent characterized by containing an extract obtained from Sasanqua. サザンカ抽出物が、サザンカの葉から得られたものであることを特徴とする請求項1に記載の抗菌剤。 The antibacterial agent according to claim 1, wherein the extract of sasanqua is obtained from leaves of sasanqua. 抗菌組成物として、サザンカ抽出物が、0.1重量%以上配合されることを特徴とする皮膚外用剤。 A topical skin preparation characterized by containing 0.1% by weight or more of sasanqua extract as an antibacterial composition.
JP2006096017A 2006-03-30 2006-03-30 Antibacterial agent Active JP4791873B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006096017A JP4791873B2 (en) 2006-03-30 2006-03-30 Antibacterial agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006096017A JP4791873B2 (en) 2006-03-30 2006-03-30 Antibacterial agent

Publications (2)

Publication Number Publication Date
JP2007269667A true JP2007269667A (en) 2007-10-18
JP4791873B2 JP4791873B2 (en) 2011-10-12

Family

ID=38672830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006096017A Active JP4791873B2 (en) 2006-03-30 2006-03-30 Antibacterial agent

Country Status (1)

Country Link
JP (1) JP4791873B2 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041473A (en) * 1983-08-15 1985-03-05 Shiraimatsu Shinyaku Kk Antimicrobial agent
JPH02276562A (en) * 1989-04-19 1990-11-13 Mitsui Norin Kk Antimicrobial agent
JPH07309770A (en) * 1994-05-20 1995-11-28 Narisu Keshohin:Kk Mucopolysaccharides fractionation inhibitor, active oxygen eliminator and cosmetic
JP2000212093A (en) * 1998-11-17 2000-08-02 Ito En Ltd Antifungal agent
JP2003342190A (en) * 2002-03-19 2003-12-03 Fancl Corp Anti-helicobacter pylori composition
WO2007108042A1 (en) * 2006-03-15 2007-09-27 Tropical Technology Center Ltd. Antiinflammatory agent

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041473A (en) * 1983-08-15 1985-03-05 Shiraimatsu Shinyaku Kk Antimicrobial agent
JPH02276562A (en) * 1989-04-19 1990-11-13 Mitsui Norin Kk Antimicrobial agent
JPH07309770A (en) * 1994-05-20 1995-11-28 Narisu Keshohin:Kk Mucopolysaccharides fractionation inhibitor, active oxygen eliminator and cosmetic
JP2000212093A (en) * 1998-11-17 2000-08-02 Ito En Ltd Antifungal agent
JP2003342190A (en) * 2002-03-19 2003-12-03 Fancl Corp Anti-helicobacter pylori composition
WO2007108042A1 (en) * 2006-03-15 2007-09-27 Tropical Technology Center Ltd. Antiinflammatory agent

Also Published As

Publication number Publication date
JP4791873B2 (en) 2011-10-12

Similar Documents

Publication Publication Date Title
JP4880816B2 (en) Skin anti-aging agent
JP2000095663A (en) Agent for external use containing plant extract
KR102142311B1 (en) Skin external composition comprising tangeretin
JP2003128512A (en) Antibacterial composition for cosmetic
JP2004043336A (en) Antimicrobial agent and cosmetic incorporated with the same
JP2011026216A (en) Cosmetic
JP2001335457A (en) Antioxidant and skin care preparation containing the same
JP2003113040A (en) Antibacterial cosmetic composition
JP2006151831A (en) Antioxidant, dna damage inhibitor or skin care preparation
JP4294640B2 (en) Antiseptic disinfectant, cosmetics or pharmaceuticals containing the antiseptic disinfectant, and antiseptic disinfection method
JP2005232125A (en) Antiseptic sterilizer, and cosmetic, medicine and food each compounded with the antiseptic sterilizer
KR20150137692A (en) Cosmetic composition comtaining Lethariella cladonioides extracts
KR20160008942A (en) A composition comprising fermented Myrothamnus flabellifolius extract and the use thereof
JP4791873B2 (en) Antibacterial agent
CA3181110A1 (en) An antimicrobial composition for tackling malodour
JP2002128632A (en) Cosmetic
JP5972732B2 (en) Antibacterial agent and external preparation for skin
Sharma et al. The Art and Science of Cosmetics: Understanding the Ingredients
JP2004300143A (en) Antiseptic bactericidal agent, and the agent-compounded cosmetic, pharmaceutical and foodstuff
JP2002128654A (en) Skin care preparation
KR20160000318A (en) Cosmetic composition containing Fir tree oil
JP6253702B2 (en) Cosmetics for external use with Connals louver extract
JP2007137768A (en) Skin or hair cosmetic
JP4773670B2 (en) Elastin-like agent and cosmetics containing the same
JP6060022B2 (en) Topical skin preparation

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090327

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110328

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110609

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110712

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110722

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140729

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4791873

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250